Doctor Meena Rao
Duke Clinical Research Institute, Durham (United States of America)
Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial
Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session: New trends in antithrombotic therapy for atrial fibrillation
This platform is supported by
